Friday, July 30, 2021

Lupin acquires Melbourne-based drug maker SCP to bolster Australia generics business

Lupin acquires Melbourne-based drug maker SCP to bolster Australia generics business As a part of the transaction, Lupin will gain access to over 60 registered products having sales of over AUD 30 million

from Moneycontrol Business News https://ift.tt/3BWpqWx

No comments:

Post a Comment

Global Market Today: Asian markets temper Iran deal optimism, BOJ decision in view

Asian stocks saw a modest rise, following a rally on news of a peace deal between Iran and the U.S. Investors are now focused on central ban...